InvestorsHub Logo
Followers 10
Posts 4272
Boards Moderated 0
Alias Born 11/12/2012

Re: FORZANANO post# 110673

Friday, 04/24/2015 2:51:50 PM

Friday, April 24, 2015 2:51:50 PM

Post# of 146212

We believe that with the new insight we have gained, and with our experience from earlier studies, we can continue to optimize our multiple drug candidates before another Ebola epidemic strikes.


This is another way of saying, "the Ebolacide2 tests were a learning experience," i.e., Ebolacide2 didn't work very well. And again, aspirin is also equally effective against Ebola and Marburg.

Herpes -- who cares? They won't be able to manufacture HSVcide in useful quantities anyway.

Flucide -- same old shit we've been getting for years. Too bad NNVC doesn't know how to make the stuff.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News